SYS1, also known as "SYS1 Golgi trafficking protein," is a relatively uncharacterized human protein encoded by the SYS1 gene. While detailed functional insights are limited, SYS1 is believed to be involved in intracellular trafficking, particularly associated with the Golgi apparatus, which is a key organelle in the processing and sorting of proteins and lipids in the cell.Based on its name and the limited available data, SYS1 may play a role in the maintenance of Golgi structure or in the regulation of vesicular transport between the Golgi and other cellular compartments. The Golgi apparatus is critical for the proper functioning of eukaryotic cells, as it is central to the secretory pathway, modifying proteins and lipids received from the endoplasmic reticulum and directing them to their final destinations.
The protein's precise mechanisms of action, its interaction partners within the Golgi trafficking machinery, and its implications for cell physiology are subjects that would benefit from further research. It is possible that SYS1 partners with other proteins that are better characterized in the context of Golgi function, and dissecting these interactions could provide a clearer picture of its role.SYS1 may also be implicated in various cellular processes that rely on effective Golgi function, such as protein glycosylation, membrane trafficking, and cell signaling. Dysregulation of such processes may have implications for various diseases, including those related to protein misfolding and trafficking disorders.
VEJA TAMBÉM
Items 1 to 10 of 12 total
Mostrar:
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
A brefeldina A perturba a estrutura e a função do Golgi, afectando potencialmente os processos de tráfico relacionados com o SYS1. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
A monensina é um ionóforo que perturba a função do Golgi, o que poderia influenciar indiretamente a atividade do SYS1. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
O nocodazol perturba a dinâmica dos microtúbulos, afectando o transporte de vesículas e podendo afetar a função do SYS1. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
O Golgicide A visa especificamente o aparelho de Golgi, influenciando potencialmente os processos relacionados com o SYS1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
A forskolina modula os níveis de AMPc, que podem influenciar vários processos celulares, incluindo potencialmente os que envolvem o SYS1. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
A tunicamicina inibe a glicosilação ligada à N no ER, afectando o tráfico de proteínas e potencialmente a atividade do SYS1. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
A cloroquina, ao alterar o pH endossomal e lisossomal, pode afetar as vias de tráfico de proteínas, com potencial impacto no SYS1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A Wortmannin é um inibidor da PI3 quinase, com impacto no tráfico de vesículas e possivelmente na função do SYS1. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
O Dynasore inibe a dinamina, afectando a endocitose e o tráfico vesicular, o que poderia influenciar o SYS1. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
O ácido retinóico influencia a diferenciação celular e pode afetar indiretamente o SYS1 através de alterações na organização celular. | ||||||